AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
3 days ago · THOUSAND OAKS, Calif., Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement on the MariTide (maridebart cafraglutide, formerly AMG 133) Phase 1 data. "As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density changes. The Phase 1 study results do not suggest any bone safety concern or change our ...
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
2 days ago · Published. Nov 13, 2024 5:00am EST. THOUSAND OAKS, Calif., Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement on the MariTide (maridebart cafraglutide, formerly ...
The Maritime Executive: Maritime News | Marine News
The maritime industry’s leading source for breaking maritime and marine news including shipping news, offshore news, piracy news and more
gCaptain – Maritime News
Discover the latest maritime news, shipping updates, and offshore industry insights at gCaptain. Trusted by mariners and shipping professionals worldwide, gCaptain delivers real-time reports ...
USNI News - Maritime News and Analysis
3 days ago · Every week, USNI News highlights U.S. Navy, Marine and Coast Guard operations around the world. Aviation News on the latest developments in U.S. and international aviation.
Marine Log - Maritime News for the Marine Industry
3 days ago · Marine Log reports news on shipyards, naval architects, vessel design and construction, shipping, cruising, and ferries.
Seatrade Maritime News | Global Maritime & Shipping News …
3 days ago · Daily maritime news covering marine, shipping and offshore updates from the global maritime industry. Sign-up for the daily maritime newsletter.
Maritime News, Maritime Magazine
Latest Maritime News. Industry Partnership to Develop Safety Guidelines for Ship-to-Ship Ammonia Bunkering. A landmark partnership to develop the safety guidelines for ship…
Amgen goes all in on injectable obesity treatment MariTide - STAT
May 2, 2024 · The injectable drug, called MariTide, is in a Phase 2 trial for obesity, and Chief Executive Bob Bradway said on an earnings call that “we are very encouraged with the results” from an interim ...
gCaptain – Maritime News
Discover the latest maritime news, shipping updates, and offshore industry insights at gCaptain. Trusted by mariners and shipping professionals worldwide, gCaptain delivers real-time reports,...